Ang1 and Tie2 are predictive biomarkers for bevacizumab-letter

Clin Cancer Res. 2015 Feb 15;21(4):934. doi: 10.1158/1078-0432.CCR-14-2832.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiopoietin-1 / genetics*
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Female
  • Humans
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / genetics*
  • Receptor, TIE-2 / genetics*

Substances

  • Angiopoietin-1
  • Antibodies, Monoclonal, Humanized
  • Receptor, TIE-2